China SXT Pharmaceuticals, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | $1.58 | $1.58 | $1.58 |
| Q2 2024 | 1 | $1.34 | $1.34 | $1.34 |
| Q3 2024 | 1 | $1.54 | $1.54 | $1.54 |
China SXT Pharmaceuticals, Inc. Earnings Date And Information
China SXT Pharmaceuticals, Inc. last posted its earnings results on N/A. The company reported $N/A earnings per share for the quarter, missing analysts' consensus estimates of $N/A by $0. The company had revenue of 494,457 for the quarter and had revenue of 1.93 M for the year. China SXT Pharmaceuticals, Inc. has generated $-4 earnings per share over the last year ($-3.57 diluted earnings per share) and currently has a price-to-earnings ratio of -0.06. China SXT Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, July 17th, 2023 based on prior year's report dates.
China SXT Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/13/2024 | Q4 2024 | $2.67 | $494,457 | $494,457 | ||
| 12/30/2023 | Q3 2024 | $2.67 | $494,457 | |||
| 09/28/2023 | Q2 2024 | -$9.67 | $939,583 | |||
| 07/31/2023 | Q1 2024 | -$9.67 | $469,792 | |||
| 07/31/2023 | Q4 2023 | -$5.14 | $763,391 | |||
| 07/31/2023 | Q3 2023 | -$5.14 | $381,696 | |||
| 09/29/2022 | Q2 2023 | -$7.30 | $1.21 M | |||
| 07/18/2022 | Q1 2023 | -$7.30 | $604,144 | |||
| 07/18/2022 | Q4 2022 | -$25.39 | $-11,502,270 | |||
| 07/18/2022 | Q3 2022 | -$25.39 | $787,304 | |||
| 01/14/2022 | Q2 2022 | -$49.71 | $1.03 M | |||
| 08/13/2021 | Q1 2022 | -$49.71 | $513,837 | |||
| 08/13/2021 | Q4 2021 | -$71.73 | $-9,326,978 | |||
| 08/13/2021 | Q3 2021 | -$71.73 | $458,536 | |||
| 09/29/2020 | Q2 2021 | $24.00 | $1.93 M | |||
| 07/31/2020 | Q1 2021 | $24.00 | $1.93 M | |||
| 07/31/2020 | Q4 2020 | -$297.04 | $5.16 M | |||
| 07/31/2020 | Q3 2020 | -$297.04 | $973,560 | |||
| 04/22/2020 | Q2 2020 | -$103.32 | $3.22 M | |||
| 08/15/2019 | Q1 2020 | -$103.32 | $1.61 M |
China SXT Pharmaceuticals, Inc. Earnings: Frequently Asked Questions
-
When is China SXT Pharmaceuticals, Inc.'s earnings date?
China SXT Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, July 17th, 2023 based off last year's report dates.
-
How can I listen to China SXT Pharmaceuticals, Inc.'s earnings conference call?
The conference call for China SXT Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
-
How can I read China SXT Pharmaceuticals, Inc.'s conference call transcript?
The conference call transcript for China SXT Pharmaceuticals, Inc.'s latest earnings report can be read online.
-
How much revenue does China SXT Pharmaceuticals, Inc. generate each year?
China SXT Pharmaceuticals, Inc. (:SXTC) has a recorded annual revenue of $1.93 M.
-
How much profit does China SXT Pharmaceuticals, Inc. generate each year?
China SXT Pharmaceuticals, Inc. (:SXTC) has a recorded net income of $1.93 M. China SXT Pharmaceuticals, Inc. has generated $-3.57 earnings per share over the last four quarters.
-
What is China SXT Pharmaceuticals, Inc.'s price-to-earnings ratio?
China SXT Pharmaceuticals, Inc. (:SXTC) has a price-to-earnings ratio of -0.06 and price/earnings-to-growth ratio is -0.
